Understanding your Additional Cost
We have a number of additional treatments and techniques available which may improve the potential for treatment success for some patients. We only offer these to patients based on their individual medical history and/or previous fertility treatment outcomes or pre consultation screening tests, or at patient request. These are additional to standard IVF and cost extra. We will always be clear about any additional costs, research, success rates, risks and HFEA comments related to these treatments and techniques.
PGT-A is a screening test performed on embryos produced during IVF treatment. It gives information about the genetic health of an embryo to help us select the embryos with the most potential.
PGT-A testing can’t change the number of viable embryos available for transfer, or improve embryo health, but by only transferring the embryos that are chromosomally normal, the time to pregnancy can be shorter and the distress of failed treatment and risks of miscarriage can be reduced.
There is an additional charge of £1,360 for PGT-A testing, plus £355 per embryo biopsied. The fee includes treatment set up, biopsy set up and Caremaps.
Caremaps-AI®, our time-lapse imaging technique powered by artificial intelligence, has been designed to help us choose the embryo with the most potential without genetic testing.
Caremaps can’t change your embryos but it can help us choose the one which is most likely to establish a pregnancy. We believe that Caremaps can help all of our patients.
There is an additional charge of £995 for Caremaps-AI
Endometrial Receptivity Array (ERA) is a method of assessing the best time to transfer your embryo so that the embryo has the best chance of implanting and establishing a pregnancy. The womb lining (or endometrium) is only receptive to implantation for a short period, known as the implantation window.
The procedure involves testing a sample of the womb lining and monitoring 248 genes, which, some studies suggest, regulate when the implantation window is open.
There is an additional charge of £1300 (£1475 at Care London) for ERA
EMMA & ALICE tests
EMMA (Endometrial Microbiome Metagenomic Analysis) and ALICE (Analysis of Chronic Infective Endometritis) are screening tests that assess bacteria in the uterine cavity.
It is usual for there to be bacteria in the uterine cavity however, studies show that the presence of types that cause inflammation or illness may be associated with embryo implantation failure.
EMMA includes a complete screen of endometrial bacteria, including those affecting fertility.
ALICE is a more focused but limited test that looks specifically for bacteria that cause chronic, low-grade infection of the womb lining (endometritis).
There is an additional charge that ranges from £1,495 - £1,560 for EMMA and ALICE testing.
SOS (Sperm Oxidative Stress Testing)
Our SOS (Sperm Oxidative Stress) test determines if a patient hashigh levels of oxidative stress by assessing the balance of free radicals and antioxidants in a semen sample. The results help us tailor your fertility advice and treatment.
A classic semen analysis may show the effects of oxidative stress (such as reduced quality or motility of sperm) but not show the reason behind it.
This test can be done at the same time as a normal semen analysis, or at any other time during fertility treatment at Care.
We charge an additional fee of £110 for SOS testing.
Zymot Sperm Selection
ZyMõt has been designed to mimic the body’s natural mode of sperm selection. ZyMõt is a device, also called a chip, which can be used in the IVF laboratory to prepare and select sperm for (ICSI). ZyMōt ‘microfluidic’ sperm preparation is designed to select motile sperm with the lowest levels of DNA fragmentation compared to conventional sperm preparation techniques.
There is an additional charge of £230 (£290 at Care London) for ZyMōt.If you request the use of ZyMōt, an embryologist will be able to advise on the day of your ICSI treatment if ZyMōt cannot be used, and any fees for this will be refunded.
EmbryoGlue® isn’t glue as you know it; it’s made with a substance – hyaluronan – that makes the embryo more likely to stick to the lining of the womb. If you decide to use EmbryoGlue® in your treatment, it will replace the standard culture medium that we use for embryo transfer following ICSI or IVF. The embryo(s) selected for transfer are placed into EmbryoGlue® and are cultured for a short time up to the point of embryo transfer. The embryo transfer procedure remains the same, although the embryo is transferred in EmbryoGlue®.
There is an additional charge of £345 for Embryoglue
EmbryoGen and BlastGen
EmbryoGen and BlastGen are culture mediums used for culturing embryos in the lab. EmbryoGen and BlastGen solutions are a type of culture media, which are liquids designed to closely mimic the natural surroundings of an embryo. This can help embryos to grow better and make a successful embryo transfer and implantation more likely.
There is an additional charge for EmbryoGen and BlastGen of £520
Careunity is designed to help people who have experienced repeated unexplained miscarriages or unexplained implantation failure with IVF. It looks at a genetic "mutation" or "variation" in a specific gene carried on chromosome no. 4. The specific gene is Annexin A5 and is associated with and responsible for normal blood clotting in the body.
Careunity is our unique screening test that identifies the presence of this variant in those providing sperm or eggs for fertility treatment. If either the sperm or egg provider has this variant then there is at least a 50% chance it will be present in the embryo.
Our own patient data shows that anyone carrying the variant can achieve the same pregnancy rates after IVF as those without the condition.
Who can Careunity help?
We’d recommend the test to all patients who have had recurrent miscarriages or recurrent failed implantation. Because the risk is the same if either the egg or sperm provider carries the genetic variant, the screening is only effective if both are tested.
There is an additional charge for Careunity - £190 to test one partner only, £240 for both.